Logo Image
News
Latest NewsFDA NewsAdverse Event ManagementSupportive CareDisparities in Cancer CareDrug SafetyRadiation OncologySurvivorship Practice ManagementPreventionContributorsSponsored
Media
Expert ConnectionsMorning RoundsThe VitalsPodcastsVideosBetween the LinesFrom All AnglesMeeting of the MindsShortsTraining Academy
Conferences
Conference CoverageConference Listing
Publications
More
CME/CE
Continuing Education
Resources
Case-Based Digest Rx Road MapEventsAdvanced Practice Corner
Partners

Subscribe

  • News
  • Media
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • Partners
  • Brain Cancer
  • Breast Cancer
    • Metastatic Breast Cancer
  • Gastrointestinal Cancer
    • Colorectal Cancer
    • Liver Cancer
    • Gastric Cancers
  • Genitourinary Cancer
    • Kidney Cancer
    • Bladder Cancer
    • Prostate Cancer
  • Gynecologic Cancers
    • Endometrial Cancer
    • Cervical Cancer
    • Ovarian Cancer
  • Head and Neck Cancers
  • Hematology
    • Leukemia
    • Graft-Vs-Host Disease
    • Myeloproliferative Neoplasms
    • Multiple Myeloma
    • Lymphoma
  • Lung Cancer
  • Pediatric Cancer
  • Sarcomas
  • Skin Cancer
    • Melanoma
Advertisement

MMRF

Advertisement

Articles by MMRF

Multiple Myeloma Research Foundation Receives Highest Rating from Charity Navigator for Exceptional Fiscal Management

ByMMRF
June 20th 2018

The MMRF was honored for the 15th year for outstanding stewardship of donors’ funds.

Advertisement

Latest Updated Articles

  • Multiple Myeloma Research Foundation Receives Highest Rating from Charity Navigator for Exceptional Fiscal Management
    Multiple Myeloma Research Foundation Receives Highest Rating from Charity Navigator for Exceptional Fiscal Management

    June 20th 2018



Advertisement
Advertisement

Trending on Oncology Nursing News

1

Managing Rash and Stomatitis With Daraxonrasib in Pancreatic Cancer

2

Nursing Guide to Managing Lorlatinib in ALK+ NSCLC: 7-Year CROWN Insights

3

GLP-1 RAs Linked to Lower HR+ Breast Cancer Risk and Improved Survival

4

FDA Approves Oral Nilotinib Tablets for Ph+ CML

5

Pembrolizumab Improves 7-Year OS in Early-Stage TNBC: KEYNOTE-522 Final Data

  • About Us
  • Editorial Board
  • Contact Us
  • CancerNetwork.com
  • CureToday.com
  • OncLive.com
  • TargetedOnc.com
  • Advertise
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us